Leyla Fouani

484 total citations
7 papers, 413 citations indexed

About

Leyla Fouani is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Leyla Fouani has authored 7 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Leyla Fouani's work include Mechanisms of cancer metastasis (5 papers), Cancer Mechanisms and Therapy (4 papers) and Trace Elements in Health (2 papers). Leyla Fouani is often cited by papers focused on Mechanisms of cancer metastasis (5 papers), Cancer Mechanisms and Therapy (4 papers) and Trace Elements in Health (2 papers). Leyla Fouani collaborates with scholars based in Australia, Hong Kong and China. Leyla Fouani's co-authors include Žaklina Kovačević, Des R. Richardson, Danuta S. Kalinowski, Patric J. Jansson, Darius J.R. Lane, Sumit Sahni, Sharleen V. Menezes, Michael Huang, Angelica M. Merlot and Nicole A. Seebacher and has published in prestigious journals such as Molecular Pharmacology, Antioxidants and Redox Signaling and Carcinogenesis.

In The Last Decade

Leyla Fouani

7 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leyla Fouani Australia	7	201	178	93	81	53	7	413
Jacky Wong United States	5	273 1.4×	237 1.3×	115 1.2×	91 1.1×	49 0.9×	6	555
Hana Jansová Czechia	13	149 0.7×	105 0.6×	62 0.7×	59 0.7×	26 0.5×	19	365
Jennifer L. Allensworth United States	7	132 0.7×	281 1.6×	34 0.4×	48 0.6×	23 0.4×	7	493
Sarah Lowndes United Kingdom	7	157 0.8×	114 0.6×	48 0.5×	102 1.3×	14 0.3×	10	455
Elin Jerremalm Sweden	9	245 1.2×	227 1.3×	86 0.9×	58 0.7×	28 0.5×	9	513
Dazhi Cen United States	4	112 0.6×	223 1.3×	38 0.4×	72 0.9×	12 0.2×	7	474
Dinesh Chimmanamada United States	6	98 0.5×	170 1.0×	82 0.9×	103 1.3×	8 0.2×	7	383
Zaihui Zhang Canada	13	110 0.5×	436 2.4×	269 2.9×	53 0.7×	66 1.2×	31	792
Mahan Gholam Azad Australia	10	106 0.5×	104 0.6×	63 0.7×	47 0.6×	19 0.4×	22	308
Myron K. Evans United States	7	106 0.5×	228 1.3×	17 0.2×	50 0.6×	20 0.4×	12	425

Countries citing papers authored by Leyla Fouani

Since Specialization

Citations

This map shows the geographic impact of Leyla Fouani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leyla Fouani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leyla Fouani more than expected).

Fields of papers citing papers by Leyla Fouani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leyla Fouani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leyla Fouani. The network helps show where Leyla Fouani may publish in the future.

Co-authorship network of co-authors of Leyla Fouani

This figure shows the co-authorship network connecting the top 25 collaborators of Leyla Fouani. A scholar is included among the top collaborators of Leyla Fouani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leyla Fouani. Leyla Fouani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Fouani, Leyla, Michael Huang, Louise Cole, et al.. (2020). During mitosis ZEB1 “switches” from being a chromatin-bound epithelial gene repressor, to become a microtubule-associated protein. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(7). 118673–118673. 6 indexed citations

Menezes, Sharleen V., Leyla Fouani, Michael Huang, et al.. (2018). The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin expression in pancreatic cancer cells. Carcinogenesis. 40(6). 805–818. 56 indexed citations

Fouani, Leyla, Žaklina Kovačević, & Des R. Richardson. (2017). Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment. Antioxidants and Redox Signaling. 30(8). 1096–1123. 23 indexed citations

Menezes, Sharleen V., Leyla Fouani, Danuta S. Kalinowski, et al.. (2017). Novel Thiosemicarbazones Inhibit Lysine-Rich Carcinoembryonic Antigen–Related Cell Adhesion Molecule 1 (CEACAM1) Coisolated (LYRIC) and the LYRIC-Induced Epithelial-Mesenchymal Transition via Upregulation of N-Myc Downstream-Regulated Gene 1 (NDRG1). Molecular Pharmacology. 91(5). 499–517. 23 indexed citations

Park, Kyung Chan, Leyla Fouani, Patric J. Jansson, et al.. (2016). Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics. Metallomics. 8(9). 874–886. 111 indexed citations

Fouani, Leyla, et al.. (2016). Metals and metastasis: Exploiting the role of metals in cancer metastasis to develop novel anti-metastatic agents. Pharmacological Research. 115. 275–287. 61 indexed citations

Jansson, Patric J., Danuta S. Kalinowski, Darius J.R. Lane, et al.. (2015). The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the “Triad of Death” in cancer by Di-2-pyridylketone thiosemicarbazones. Pharmacological Research. 100. 255–260. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact